Award notice
🇪🇺 TED
312969-2026
Alpelisib comprimidos, Asciminib comprimidos, Basiliximab vial, Brolucizumab jeringa/pluma precargada, Canakinumab vial, Capmatinib comprimidos, Ceritinib cápsulas, Dabrafenib cápuslas, Midostaurina cápsulas, Ofatumumab pluma precargada, Ribociclib comprimidos, Ruxolitinib comprimidos, Secukinumab jeringa/ pluma precargada, Siponimod comprimidos, Trametinib comprimidos.
🌍 ES
Publication
07/05/2026
Date limite
—
Devise estimée
EUR
Acheteur
—
Contenu du marché
Extrait automatiquementDescription
uministro de medicamentos de uso humano que contiene los principios activos siguientes: alpelisib, asciminib, basiliximab, brolucizumab, canakinumab, capmatinib, ceritinib, dabrafenib, midostaurina, ofatumumba, ribociclib, ruxolitinib, secukinumab, siponimod y trametinib, con destino a los centros del ámbito de la sanidad pública valenciana
Valeur estimée
224 059 794,97 EUR
Date limite
07/05/2026
Type de procédure
Negotiated without prior call for competition
Région
Valencia / València (ES523)
Critères d'attribution
Criterion: Type: Price Description: Precio. Category of award weight criterion: Weight (points, exact) Award criterion number: 100
Secteur
Immunosuppressive agents
Marchés similaires
Contract notice
08/05/2026
NHS Lothian Radiotherapy Linacs
GB
Prior notice
08/05/2026
Managed Service for Endoscopy, Radiology, Cath Labs & CTC, and Theatres – Preliminary Market Engagement (Market Engagement Event)
GB
Prior notice
08/05/2026
Procurement of 1 No Navigational Robot-assisted Bronchoscopy platform
GB
J-145
Prior notice
08/05/2026
Supply of Independent Living Equipment
GB